Submitted by Anonymous (not verified) on 16 February 2026 - 9:30
Human medicines European public assessment report (EPAR): Yesintek, ustekinumab, Date of authorisation: 14/02/2025, Revision: 3, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Yesintek, ustekinumab, Date of authorisation: 14/02/2025, Revision: 3, Status: Authorised